Medtronic Wins Nod for TAVR System Ahead of TCT 2019

Medtronic Wins Nod for TAVR System Ahead of TCT 2019

Source: 
Medical Devices and Diagnostics Industry
snippet: 

The Dublin-based company has received FDA approval for the Evolut PRO+ TAVR System. An analyst with Canaccord Genuity said there would be some key updates from TAVR clinical trials at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 meeting held later this week.